Bridgewater Associates’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,577
Closed -$425K 912
2024
Q1
$425K Sell
14,577
-2,302
-14% -$64.4K ﹤0.01% 636
2023
Q4
$549K Sell
16,879
-1,688
-9% -$48.9K ﹤0.01% 699
2023
Q3
$594K Buy
18,567
+6,288
+51% +$242K ﹤0.01% 673
2023
Q2
$538K Buy
+12,279
New +$566K ﹤0.01% 643
2022
Q4
Sell
-21,888
Closed -$1.01M 888
2022
Q3
$1.01M Sell
21,888
-826
-4% -$40.5K 0.01% 698
2022
Q2
$980K Buy
22,714
+2,783
+14% +$127K ﹤0.01% 793
2022
Q1
$1.08M Buy
19,931
+4,509
+29% +$230K ﹤0.01% 793
2021
Q4
$923K Sell
15,422
-4,274
-22% -$266K 0.01% 590
2021
Q3
$1.29M Sell
19,696
-859
-4% -$55.8K 0.01% 482
2021
Q2
$1.3M Buy
+20,555
New +$1.18M 0.01% 545

Other funds holding KIDS

Bridgewater Associates's KIDS Position: Q2 2024 in Review

Bridgewater Associates sold out of OrthoPediatrics (KIDS) in Q2 2024, closing a stake of 14,577 shares — an estimated $425K sold.

Bridgewater Associates first reported a position in KIDS in Q2 2021 and held it in 10 quarters. The position peaked at $1.3M in Q2 2021. 122 funds tracked by Wall St. Rank hold KIDS as of Q2 2024.

  • Bridgewater Associates reported no remaining OrthoPediatrics position as of Q2 2024 after selling out during the quarter.
  • Bridgewater Associates sold 14,577 OrthoPediatrics shares in Q2 2024, an estimated $425K.
  • Bridgewater Associates first reported a position in OrthoPediatrics in Q2 2021 and held it in 10 quarters.
  • Bridgewater Associates's OrthoPediatrics position peaked at $1.3M in Q2 2021.
  • 122 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2024.

Based on Bridgewater Associates's 13F filing for Q2 2024, filed 14 Aug 2024.